Clinical Scorecard: Exploring the Nonlinear Relationships Among Serum Insulin Levels, Visceral Fat Area, and Renal Function in Women with Type 2 Diabetes: A Retrospective Analysis

At a Glance

Key Highlights

• Significant nonlinear effects observed between fasting insulin, visceral fat area, and eGFR, with clinical implications for patient management.
• Threshold for fasting insulin identified at 70.28 pmol/L; above this, negatively correlated with eGFR, indicating potential risk for renal impairment.
• Visceral fat area threshold at 73.6 cm²; below this, positively correlated with eGFR, suggesting protective effects on renal function.
• Study included 595 female patients after excluding incomplete data, ensuring robust findings.
• Provides quantitative evidence for risk stratification of renal function in female patients with T2DM, emphasizing the need for targeted interventions.

Guideline-Based Recommendations

Diagnosis

Management

• Consider thresholds for fasting insulin and visceral fat area in managing renal function, including potential pharmacological or lifestyle interventions.

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Female patients with Type 2 Diabetes Mellitus.

Insulin levels and visceral fat area are critical in assessing renal function.

Clinical Best Practices

• Incorporate fasting insulin and visceral fat area measurements in routine assessments, with specific protocols for monitoring changes over time.
• Utilize eGFR as a key indicator for renal function in T2DM patients, with guidelines for follow-up based on eGFR trends.

Related Resources & Content

• International Diabetes Federation
• Diabetic Kidney Disease Overview